The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
Sabine Royalty Trust SBR
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
read at $73.01
Sabine Royalty Trust holds its Markdown at $73.01.
- PHPhase · the trend structure carries the Markdown label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 9 days |
| Price | $73.01 |
| Valuation | 15.57 trailing · N/A forward price to earnings |
| Values screen | PASS |
| Beta | 0.22 |
The business, in plain words · what the numbers mean
| Trailing P/E | 15.6x reasonably valued |
| Revenue growth | -26.9% revenue is shrinking |
| Profit margin | 94.5% highly profitable on every dollar of sales |
| Return on equity | 832.9% an exceptional return on shareholder capital |
| Current ratio | 22.32 comfortably covers its short-term bills |
| Beta | 0.22 barely tracks the market's swings |
| Market cap | $1.1B |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in SBR's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
SBR trades on the NYSE. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $75.32 | +3.9% | $0.50 | $1,046 | +4.6% |
| 2 months | $74.96 | +4.4% | $0.82 | $1,055 | +5.5% |
| 3 months | $72.87 | +7.4% | $1.11 | $1,089 | +8.9% |
| 6 months | $69.23 | +13.1% | $1.91 | $1,158 | +15.8% |
| 1 year | $61.49 | +27.3% | $4.74 | $1,350 | +35.0% |
| 2 years | $58.54 | +33.7% | $9.93 | $1,507 | +50.7% |
| 3 years | $53.43 | +46.5% | $15.78 | $1,760 | +76.0% |
| 5 years | $24.89 | +214.4% | $29.57 | $4,332 | +333.2% |
Historical returns from market close data. Past performance does not guarantee future results.